ELI LILLY & Co·4

Feb 3, 4:26 PM ET

Hernandez Edgardo 4

Research Summary

AI-generated summary

Updated

Eli Lilly (LLY) EVP Edgardo Hernandez Exercises RSUs

What Happened
Edgardo Hernandez, EVP & President, Manufacturing Operations at Eli Lilly, converted/vested 3,572 restricted stock units (reported as derivative exercise) on 2026-02-01. As part of the settlement, 1,591.452 shares were withheld to satisfy tax withholding at $1,037.15 per share, reported as a disposition (code F) totaling $1,650,574. The RSU conversion is reported with $0 exercise price (typical for RSUs).

Key Details

  • Transaction date: 2026-02-01; filing date: 2026-02-03 (timely Form 4).
  • Converted/vested: 3,572 RSUs → 3,572 shares (reported as code M).
  • Tax withholding: 1,591.452 shares withheld at $1,037.15/share = $1,650,574 (reported as code F).
  • Net shares received: 3,572 − 1,591.452 = 1,980.548 shares (calculated from filing entries).
  • Footnote: Each restricted stock unit equals a contingent right to one share (F1).
  • Shares owned after the transaction: not specified in the excerpt of the filing.

Context
This was a routine RSU vesting and tax-withholding event (not an open-market purchase or discretionary sale). The filing shows conversion of RSUs and withholding to cover taxes (a common cashless settlement), which does not by itself indicate a bullish or bearish view by the insider.